Tim Hammond

Professor Tim Hammond has 35 years of experience in pharmaceutical drug Discovery and Development and was a former Vice President of Safety Assessment in the UK for AstraZeneca. He has experience in the selection of Candidate Drugs for Clinical Development as well as a wide experience in regulatory sciences required to take candidate drugs through each phase of clinical development up to and including marketing authorization. Since retiring from AstraZeneca he has been an independent consultant supporting small, medium, and major pharmaceutical companies as well as Universities and Charity organizations devoted to the Discovery and Development of new medicines.

Professor Hammond has experience in supporting Drug Discovery and Development within a wide range of therapeutic areas including oncology, respiratory, inflammation, neuroscience, and cardiovascular. For more than 10 years in AstraZeneca Tim was the senior preclinical scientist on the First Time in Human Safety Board.